Press Release Polyplus launches FectoVIR®-AAV GMP transfection reagent for large scale viral vector production 10/08/2021 (5 months)
Press Release Polyplus invests in Shanghai commercial offices to expand localized cell and gene therapy sector supply 29/07/2021 (6 months)
Press Release Polyplus-transfection appoints Marc Funk to its Board of Directors 30/03/2021 (10 months)
Press Release Polyplus-transfection acquires Biowire to further expand into Asia-Pacific gene and cell therapy markets 09/03/2021 (10 months)
Press Release Polyplus-transfection initiates construction of Vectura, a new 4,000m2 facility 27/01/2021 (12 months)
Press Release Polyplus-transfection Names Mario Philips As Chief Executive Officer 03/11/2020 (1 year)
Press Release Polyplus-transfection® expands GMP portfolio to deliver flexibility for gene and cell therapy manufacturing 19/02/2020 (1 year)
Press Release in vivo-jetRNA® transfection reagent for vaccination and cancer research 29/10/2019 (2 years)
